BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Agile Therapeutics, Inc. Announces Dosing Of First Patients In Twirla® Phase 3 SECURE Study

  September 29, 2014

   · 

  4 min read
• Drug Development

  Bionomics Limited Presents BNC105 Phase 2 Renal Cancer Trial Biomarker Data

  September 29, 2014

   · 

  5 min read
• Drug Development

  Acasti Pharmai Reports Successful Capre® Phase 2 TRIFECTA Results Proving Statistically Significant Improvements In Triglycerides & Non-HDL-C

  September 29, 2014

   · 

  10 min read
• Biomedic Acetaminophen With Codeine: Recall Due To Missing Child-Resistant Packaging

  September 29, 2014

   · 

  1 min read
• Business

  Kamada Ltd. Extends Glassia Agreement With Baxter International, Inc.

  September 29, 2014

   · 

  6 min read
• Business

  Horizon Pharma plc. Commercial Chief Resigns; Executive Committee Formed

  September 29, 2014

   · 

  4 min read
• Business

  LINK Appoints New CEO

  September 29, 2014

   · 

  3 min read
• Drug Development

  Endocyte, Inc. Release: Phase 2b TARGET Trial Results Show Improved Survival In Adenocarcinoma Non-Small Cell Lung Cancer Patients Treated With Endocyte’s Vintafolide

  September 29, 2014

   · 

  7 min read
• Genetown

  EMD Serono Announces Award Of $1.3 Million To The Winners Of The First Grant For Oncology Innovation

  September 29, 2014

   · 

  3 min read
• Drug Development

  CytRx Corporation Receives Multiple FDA Orphan Drug Designations For Aldoxorubicin For The Treatment Of Glioblastoma, Small Cell Lung Cancer And Ovarian Cancer

  September 29, 2014

   · 

  7 min read